Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial

Table 4 Main outcome baseline data comparison

Measure	Group	N	Mean	Std. Deviation	p-value
YBOCS – week 0	control	14	28.8571	7.26273	0.21
YBOCS – week 0	intervention	15	31.6000	3.83219	0.21
OBSE– week 0	control	14	15.0714	3.49647	0.30
OBSE– week 0	intervention	15	16.2000	2.14476	0.30
COMP-week 0	control	14	13.7857	4.35322	0.22
COMP-week 0	intervention	15	15.4000	2.50143	0.22
BDI– week 0	control	14	19.8571	3.43863	0.26
BDI– week 0	intervention	15	31.1333	36.62721	0.26
BAI– week 0	control	14	37.9286	15.13765	0.78
BAI– week 0	intervention	15	39.2667	10.55236	0.78
OBQ– week 0	control	14	178.3571	30.11416	0.57
OBQ– week 0	intervention	15	184.1333	25.17898	0.57
DAS– week 0	control	14	103.6429	28.48915	0.48
DAS– week 0	intervention	15	111.8000	32.50978	0.48

ISSN: 1471-244X